Search results

Order by most recent / most popular / relevance

Results: 1-10 of 274

“Enbancworthy” - Fifth Circuit weighs in on whether company can recover funds from Special Needs Trust

Alston & Bird LLP
-
USA
-
May 16 2013

"The question this court deems enbancworthy is whether ACS Recovery Services, Inc., the administrator, and FK Industries, Inc., the sponsor

Generic manufacturer Ranbaxy settles civil and criminal claims based on cGMP violations: a new era of cGMP enforcement actions?

Alston & Bird LLP
-
USA
-
May 14 2013

Yesterday, the Department of Justice (DOJ) announced that it had entered into a $500 million civil and criminal settlement with Ranbaxy USA, Inc

Life’s a breach, part II: Omnibus Rule revises what constitutes a breach under the HIPAAHITECH breach notification requirements

Alston & Bird LLP
-
USA
-
May 8 2013

HIPAA's "Omnibus Rule" (also referred to in this advisory as the "Rule"), published on January 25, 2013, modified many parts of the HIPAA

New York Court considering equitable claim for medical monitoring

Alston & Bird LLP
-
USA
-
May 7 2013

The New York Court of Appeals may soon have to decide whether an independent equitable claim for medical monitoring is a recognized claim in New York

HIPAA, mental health, and the national instant criminal background check system

Alston & Bird LLP
-
USA
-
April 23 2013

In the aftermath of such incidents as the shootings at Virginia Tech and Newtown, HHS published guidance to remind covered entities that health care

Council for Responsible Nutrition releases recommended guidelines for caffeine-containing dietary supplements

Alston & Bird LLP
-
USA
-
April 5 2013

On April 3, 2013, the Council for Responsible Nutrition ("CRN") proposed voluntary guidelines for the labeling of dietary supplements containing

CER fees funding the patient-centered outcomes research trust

Alston & Bird LLP
-
USA
-
March 13 2013

The Patient Protection and Affordable Care Act (the "Act") includes provisions that promote research to evaluate and compare health outcomes and the

New York Supreme Court strikes down law aimed at controlling container size of sugary drinks

Alston & Bird LLP
-
USA
-
March 12 2013

In response to America's and New York's growing concern about obesity, New York City enacted 81.53 of the New York City Health Code on

New HIPAA Omnibus Rule: issues for employer plan sponsors and group health plans

Alston & Bird LLP
-
USA
-
March 11 2013

HIPAA's long-awaited "Omnibus Rule" (also referred to in this advisory as the "Rule"), published on January 25, 2013, modifies numerous aspects of

U.S. Department of Labor issues interim final rule on whistleblower protections under the Affordable Care Act

Alston & Bird LLP
-
USA
-
March 6 2013

Section 1558 of the Affordable Care Act (ACA) protects employees against retaliation by an employer for reporting alleged violations of Title I of

next >

Search results

“Enbancworthy” - Fifth Circuit weighs in on whether company can recover funds from Special Needs Trust

Generic manufacturer Ranbaxy settles civil and criminal claims based on cGMP violations: a new era of cGMP enforcement actions?

Life’s a breach, part II: Omnibus Rule revises what constitutes a breach under the HIPAAHITECH breach notification requirements

New York Court considering equitable claim for medical monitoring

HIPAA, mental health, and the national instant criminal background check system

Council for Responsible Nutrition releases recommended guidelines for caffeine-containing dietary supplements

CER fees funding the patient-centered outcomes research trust

New York Supreme Court strikes down law aimed at controlling container size of sugary drinks

New HIPAA Omnibus Rule: issues for employer plan sponsors and group health plans

U.S. Department of Labor issues interim final rule on whistleblower protections under the Affordable Care Act

Current Search

Suggested Facets

Author

Jurisdiction

Workarea